Activity of IMMU-130 anti-CEACAM5-SN-38 antibody-drug conjugate (ADC) on metastatic colorectal cancer (mCRC) having relapsed after CPT-11: Phase I study.

被引：8

作者：

Dotan, Efrat

Berlin, Jordan

Starodub, Alexander

Guarino, Michael J.

Cohen, Steven J.

Maliakal, Pius P.

Govindan, Serengulam V.

Wegener, William A.

Sharkey, Robert M.

Goldenberg, David M.

机构：

[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA

[2] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[3] Indiana Univ Hlth Goshen Ctr Canc Care, Goshen, IN USA

[4] Christiana Care Hlth Syst, Helen F Graham Canc Ctr, Newark, DE USA

[5] Immunomedics Inc, Morris Plains, NJ USA

来源：

关键词：

D O I：

10.1200/jco.2014.32.15_suppl.3106

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3106

引用

页数：1